Litcius/Paper detail

Corrigendum: Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway Inactivation

Tianyu Zhai, Xiaoyu Zhang, Zhenyu Hei, Longyang Jin, Chao Han, Audrey Tsznam Ko, Xiaofeng Yu, Jiandong Wang

2021Frontiers in Pharmacology21 citationsDOIOpen Access PDF

Abstract

In the published article, there was an error in the affiliations order. We need interchange the 1 and 3 in the author's superscript number and affiliations list. It should be “Tianyu Zhai1,2,3†, Xiaoyu Zhang1†, Zhenyu Hei1, Longyang Jin4, Chao Han5, Audrey Tsznam Ko6, Xiaofeng Yu7*, Jiandong Wang1,2,3*1 Department of General Surgery, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.2 Shanghai Research Center of Biliary Tract Disease, Shanghai, China.3 Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China.4 Department of Colorectal Surgery, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.5 Department of General Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.6 Faculty of Medicine, Imperial College London, London, United Kingdom.7 Department of General Surgery, People's Hospital of Gaoxin District, Suzhou, China.” The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Topics & Concepts

MedicineChinaBiliary tract cancerGeneral hospitalGeneral surgeryFamily medicineCancerInternal medicineGeographyArchaeologyGemcitabinePhytochemical and Pharmacological StudiesCancer, Lipids, and Metabolism